- (-)-Securinine
-
- $50.00 / 5mg
-
2026-04-22
- CAS:5610-40-2
- Min. Order:
- Purity: 99.87%
- Supply Ability: 10g
- SECURININE
-
- $0.00 / 25kg
-
2025-12-01
- CAS:5610-40-2
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000KGS
- SECURININE USP/EP/BP
-
- $1.10 / 1g
-
2025-11-18
- CAS:5610-40-2
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
| | SECURININE Basic information |
| | SECURININE Chemical Properties |
| Melting point | 140-1420C | | alpha | D20 -1042° (c = 1 in alc) | | Boiling point | 357.82°C (rough estimate) | | density | 1.30±0.1 g/cm3 (20 ºC 760 Torr) | | refractive index | 1.5300 (estimate) | | storage temp. | Sealed in dry,2-8°C | | solubility | DMSO: ≥25mg/mL | | pka | 8.29±0.20(Predicted) | | form | powder | | color | yellow | | Optical Rotation | [α]/D -980 to -1015 (C=1, MeOH) | | InChI | InChI=1S/C13H15NO2/c15-12-7-9-4-5-10-8-13(9,16-12)11-3-1-2-6-14(10)11/h4-5,7,10-11H,1-3,6,8H2/t10-,11-,13+/m1/s1 | | InChIKey | SWZMSZQQJRKFBP-WZRBSPASSA-N | | SMILES | N12CCCC[C@]1([H])[C@]13C[C@@]2([H])C=CC1=CC(=O)O3 |
| | SECURININE Usage And Synthesis |
| Description | A constituent of the leaves of Securinega suffructicosa Rehd., the base also occurs in Phyllanthus disco ides. It is obtained as yellow crystals and is strongly laevorotatory having [α]20D - 1106°(CHC13), [α]30D - 1106°(CHC13) and[α]20D - 1042° (c 1.0, EtOH). The alkaloid yields a crystalline methiodide, m.p. 235-6°C. | | Chemical Properties | Yellow Solid | | Uses | Extracted from leaves and roots of Securinega suffruticosa Rehder. The most widely studied of these alkaloids, Securinine, is a specific GABA receptor antagonist and has been found to have significant in vivo CNS activity. | | Uses | GABAA receptor blocker, CNS stimulant | | Definition | ChEBI: Securinine is a member of indolizines. | | in vivo | In this tumor model, tumor growth is significantly impaired with (-)-Securinine treatment indicating that (-)-Securinine has potential as an Acute Myeloid Leukemia (AML) therapeutic. (-)-Securinine treated mice (n=5 mice, bilateral tumors), exhibit an average of more than 75% smaller tumors than vehicle treated mice at the end of the study period[2]. | | References | Murav'eva, Ban'kovskii., Dokl. Akad. Nauk, SSSR, 110,998 (1956)
Saito et al., Chem. & Ind., 1652 (1962)
Satoda et al., Tetrahedron Lett., 1199 (1962)
Mukherjee et al., Naturwiss., 50, 155 (1963)
Nakano et aI., Chem. & Ind., 1763 (1963)
Horii et al., ibid, 664 (1964)
Bevan et aI., ibid, 838 (1964)
Absolute configuration:
Bevan et al., Chern. Ind., 838 (1964)
Imadoetal., ibid, 1691 (1964)
Synthesis:
Horii et al., Tetrahedron, 23, 2265 (1967) |
| | SECURININE Preparation Products And Raw materials |
|